|
Market Closed -
Australian S.E.
01:10:22 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 7.120 AUD | +0.71% |
|
-5.82% | -42.86% |
Company Valuation: Clinuvel Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 733.7 | 883.5 | 769.8 | 520.3 | 518.4 | 359 | - | - |
| Change | - | 20.4% | -12.87% | -32.41% | -0.36% | -30.74% | - | - |
| Enterprise Value (EV) 1 | 612.2 | 726.6 | 585.9 | 296.2 | 309.1 | 75.94 | 43.43 | 5.94 |
| Change | - | 18.69% | -19.37% | -49.45% | 4.37% | -75.44% | -42.81% | -86.32% |
| P/E | 36.8x | 30.3x | 22x | 14.5x | 15.4x | 10.3x | 9.94x | 6.97x |
| PBR | 5.84x | 5.37x | 3.79x | 2.17x | 1.91x | 1.18x | 1.06x | 0.93x |
| PEG | - | 0.6x | 1.2x | 5.06x | -2.21x | 3.1x | 2.64x | 0.2x |
| Capitalization / Revenue | 11.2x | 11.3x | 8.73x | 5.48x | 5.51x | 3.8x | 3.58x | 2.67x |
| EV / Revenue | 9.32x | 9.28x | 6.64x | 3.12x | 3.29x | 0.8x | 0.43x | 0.04x |
| EV / EBITDA | 16.4x | 19.5x | 12x | 6.84x | 8.09x | 2.01x | 1.11x | 0.1x |
| EV / EBIT | 16.7x | 20x | 12.3x | 7.03x | 8.31x | 2.07x | 1.14x | 0.11x |
| EV / FCF | 15.5x | 20.2x | 18.6x | 7.26x | 8.76x | 2.08x | 1.08x | 0.11x |
| FCF Yield | 6.44% | 4.94% | 5.37% | 13.8% | 11.4% | 48.2% | 92.6% | 940% |
| Dividend per Share 2 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.0547 | 0.0592 | 0.0832 |
| Rate of return | 0.27% | 0.28% | 0.33% | 0.48% | 0.49% | 0.77% | 0.83% | 1.17% |
| EPS 2 | 0.403 | 0.591 | 0.698 | 0.718 | 0.668 | 0.6902 | 0.7162 | 1.021 |
| Distribution rate | 9.93% | 8.46% | 7.16% | 6.96% | 7.49% | 7.92% | 8.26% | 8.15% |
| Net sales 1 | 65.72 | 78.32 | 88.18 | 95.02 | 94.02 | 94.47 | 100.4 | 134.4 |
| EBITDA 1 | 37.44 | 37.2 | 48.95 | 43.3 | 38.2 | 37.75 | 39.3 | 57.96 |
| EBIT 1 | 36.68 | 36.41 | 47.81 | 42.12 | 37.21 | 36.65 | 38.13 | 56.47 |
| Net income 1 | 20.88 | 30.6 | 35.64 | 36.17 | 33.92 | 34.94 | 36.32 | 51.72 |
| Net Debt 1 | -121.5 | -156.8 | -183.9 | -224.1 | -209.3 | -283.1 | -315.6 | -353.1 |
| Reference price 2 | 14.850 | 17.880 | 15.370 | 10.380 | 10.280 | 7.120 | 7.120 | 7.120 |
| Nbr of stocks (in thousands) | 49,410 | 49,410 | 50,083 | 50,124 | 50,428 | 50,428 | - | - |
| Announcement Date | 8/30/22 | 8/29/23 | 8/28/24 | 8/27/25 | 8/27/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CUV Stock
- Valuation Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















